AI-generated analysis. Always verify with the original filing.
Aprea Therapeutics, Inc. issued a press release on February 18, 2026, announcing the second unconfirmed partial response observed in a patient. This clinical update is disclosed under Item 8.01 Other Events and attached as Exhibit 99.1.
Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 18, 2026, Aprea Therapeutics, Inc. issued a press release announcing the second unconfirmed partial response (uPR) observed in a patie
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Title 99.1 Press Release of Aprea Therapeutics, Inc., dated February 18, 2026. 104 Cover Page In